tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RAPT Stock Latest News

RAPT Therapeutics Announces Development Plans for RPT904
Company AnnouncementsRAPT Therapeutics Announces Development Plans for RPT904
3d ago
8K
RAPT
Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity
PremiumThe Fly
Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity
7d ago
NVS
CHRO
Rapt Therapeutics initiated with a Buy at Clear Street
PremiumThe Fly
Rapt Therapeutics initiated with a Buy at Clear Street
7d ago
RAPT
RAPT Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
RAPT Therapeutics Faces Nasdaq Delisting Notice
15d ago
8K
RAPT
Rapt Therapeutics price target lowered to $1 from $2 at UBS
PremiumThe Fly
Rapt Therapeutics price target lowered to $1 from $2 at UBS
21d ago
RAPT
Rapt Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyRapt Therapeutics assumed with a Buy at H.C. Wainwright
21d ago
RAPT
RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
Premium
Ratings
RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
1M ago
RAPT
RAPT Therapeutics Reports Improved Q1 2025 Results
Premium
Company Announcements
RAPT Therapeutics Reports Improved Q1 2025 Results
1M ago
RAPT
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
PremiumThe Fly
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
1M ago
RAPT
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
PremiumThe Fly
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
2M ago
RAPT
RAPT Therapeutics Announces Board Restructuring in 2025
PremiumCompany Announcements
RAPT Therapeutics Announces Board Restructuring in 2025
3M ago
8K
RAPT
RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
PremiumRatings
RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
3M ago
RAPT
Promising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
PremiumRatingsPromising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
3M ago
RAPT
RAPT Therapeutics Focuses on RPT904 Development in 2025
Premium
Company Announcements
RAPT Therapeutics Focuses on RPT904 Development in 2025
3M ago
RAPT
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
Premium
The Fly
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
3M ago
RAPT
RAPT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RAPT Earnings this Week: How Will it Perform?
3M ago
RAPT
Rapt Therapeutics files to sell 176.45M shares of common stock for holders
PremiumThe Fly
Rapt Therapeutics files to sell 176.45M shares of common stock for holders
5M ago
RAPT
RAPT Therapeutics Plans Phase 2b Trials for RPT904
PremiumCompany Announcements
RAPT Therapeutics Plans Phase 2b Trials for RPT904
5M ago
8K
RAPT
RAPT Therapeutics Announces Leadership Changes and Realignment
PremiumCompany Announcements
RAPT Therapeutics Announces Leadership Changes and Realignment
5M ago
8K
RAPT
Rapt Therapeutics appoints Lyons-Williams as chair of board of directors
PremiumThe FlyRapt Therapeutics appoints Lyons-Williams as chair of board of directors
5M ago
RAPT
Wedbush hikes Apple target to high on Street: Morning Buzz
Premium
The Fly
Wedbush hikes Apple target to high on Street: Morning Buzz
6M ago
X
MA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ACRS
AVXL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >